Cohort plc (AIM:CHRT)
London · Delayed Price · Currency is GBP · Price in GBX 1,264.00
-42.00 (-3.22%)
Aug 15, 2025, 4:35 PM GMT+1
Cohort Employees
Cohort had 1,500 employees as of April 30, 2025. The number of employees increased by 191 or 14.59% compared to the previous year.
Employees
1,500
Change (1Y)
191
Growth (1Y)
14.59%
Revenue / Employee
180.03K GBP
Profits / Employee
12.83K GBP
Market Cap
590.53M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Apr 30, 2025 | 1,500 | 191 | 14.59% |
| Apr 30, 2024 | 1,309 | 179 | 15.84% |
| Apr 30, 2023 | 1,130 | 80 | 7.62% |
| Apr 30, 2022 | 1,050 | 45 | 4.48% |
| Apr 30, 2021 | 1,005 | 99 | 10.93% |
| Apr 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Rolls-Royce Holdings | 42,400 |
| RELX PLC | 36,400 |
| BAE Systems | 107,400 |
| Experian | 23,300 |
| Ashtead Group | 25,041 |
| International Consolidated Airlines Group | 74,378 |
| Halma | 9,000 |
| Rentokil Initial | 68,485 |
Cohort News
- 2 months ago - Rallybio Initiates Dosing in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study - Benzinga
- 6 months ago - Cohort plc: High Growth Aerospace And Defense Play With Steep Valuation - Seeking Alpha
- 6 months ago - Cohort expands global reach Down Under with new acquisition - The Armchair Trader
- 8 months ago - U.S. Global Launches Technology And Aerospace & Defense ETF: Why Its Allocation Makes Sense - Benzinga
- 8 months ago - Half Year 2025 Cohort PLC Earnings Presentation Transcript - GuruFocus
- 8 months ago - Half Year 2025 Cohort PLC Analyst presentation Q&A Transcript - GuruFocus
- 9 months ago - Visa Accelerator Program Africa selects Cohort 3 - Zawya
- 11 months ago - Nano-Cap Theriva Biologics' Investigational Drug For Transplant-Related Complication Shows Safety In Bone Marrow Transplant Patients - Benzinga